ADVANCED CARDIOVASCULAR LIFE SUPPORT (ACLS)

Advanced Cardiovascular Life Support (ACLS) is a set of clinical interventions used in the urgent treatment of cardiac arrest, stroke, and other life-threatening medical emergencies. ACLS builds on the basic life support (BLS) skills and incorporates advanced interventions like airway management, use of medications, and cardiac monitoring to improve patient outcomes.

Components of ACLS:

BLS Assessment:

1. • Always start with BLS to ensure scene safety, check responsiveness, and assess for breathing and pulse.
   • Initiate chest compressions and rescue breaths (30:2 ratio) while ensuring high-quality CPR.
   • Continue with AED application as necessary.

Primary Survey (ABCDE Approach):

1. • A (Airway): Assess and secure the airway. Use advanced airway management techniques such as endotracheal intubation or supraglottic airway devices if indicated.
   • B (Breathing): Ensure adequate ventilation and oxygenation. Administer 100% oxygen and provide positive pressure ventilation as needed.
   • C (Circulation): Establish IV or IO access for drug administration. Assess rhythm, blood pressure, and perfusion. Provide drugs based on the rhythm analysis.
   • D (Disability): Assess neurological function using the Glasgow Coma Scale (GCS). Consider causes of altered mental status.
   • E (Exposure): Expose the patient to look for signs of trauma, bleeding, or other medical issues.

Rhythm Assessment and Cardiac Arrest Management:

1. • Shockable Rhythms:
     • Ventricular Fibrillation (VF) and Pulseless Ventricular Tachycardia (VT):
       • Defibrillation: Administer an unsynchronized shock (biphasic 200J or equivalent for monophasic) as soon as the rhythm is identified.
       • CPR: Perform 2 minutes of CPR immediately after the shock, without checking for pulse.
       • Medications:
         • Epinephrine 1 mg IV/IO every 3-5 minutes.
         • Amiodarone 300 mg IV/IO after the third shock, with a possible repeat dose of 150 mg.
   • Non-Shockable Rhythms:
     • Asystole and Pulseless Electrical Activity (PEA):
       • CPR: Start high-quality CPR immediately.
       • Medications: Administer Epinephrine 1 mg IV/IO every 3-5 minutes.
       • Identify Reversible Causes: Search for potentially reversible causes (H’s and T’s).

Reversible Causes (H’s and T’s):

1. • H’s:
     • Hypoxia: Ensure effective ventilation and oxygenation.
     • Hypovolemia: Treat with fluid resuscitation.
     • Hydrogen ion (acidosis): Consider ventilation, sodium bicarbonate in cases of severe acidosis.
     • Hypo-/hyperkalemia: Correct based on electrolyte levels.
     • Hypothermia: Provide rewarming techniques.
   • T’s:
     • Tension Pneumothorax: Decompress using needle thoracostomy.
     • Tamponade (cardiac): Consider pericardiocentesis.
     • Toxins: Administer specific antidotes if available.
     • Thrombosis (coronary or pulmonary): Consider fibrinolysis or PCI for coronary thrombosis; thrombolysis or embolectomy for pulmonary embolism.
     • Trauma: Manage accordingly based on findings.

Medications in ACLS:

1. • Epinephrine: Vasopressor used in both shockable and non-shockable cardiac arrest at 1 mg IV/IO every 3-5 minutes.
   • Amiodarone/Lidocaine: Antiarrhythmic agents used in shockable rhythms not responding to defibrillation.
   • Atropine: Used for symptomatic bradycardia (0.5 mg IV push every 3-5 minutes, up to 3 mg).
   • Adenosine: Used for stable SVT (initial dose 6 mg IV rapid push, followed by 12 mg if required).
   • Magnesium Sulfate: Administered in cases of torsades de pointes or hypomagnesemia (1-2 g IV diluted).

Airway and Ventilation:

1. • In patients who are not adequately ventilated or for those who require advanced airway support, endotracheal intubation or supraglottic airway devices are used.
   • For patients with an advanced airway, ventilate at a rate of 1 breath every 6 seconds (10 breaths per minute), while maintaining continuous chest compressions.

Post-Cardiac Arrest Care:

1. • Optimize Hemodynamics and Ventilation: Aim for an oxygen saturation of 92-98%, maintain a PaCO₂ of 35-45 mmHg, and target a mean arterial pressure (MAP) of at least 65 mmHg.
   • Targeted Temperature Management (TTM): Initiate TTM (typically maintaining a temperature between 32°C and 36°C for 24 hours) in patients who remain comatose after ROSC.
   • Cardiac and Neurological Management: Obtain a 12-lead ECG to evaluate for myocardial infarction. Assess neurological status and consider neuroimaging if indicated.
   • Glycemic Control: Maintain blood glucose levels between 140-180 mg/dL.

Rhythm-Specific Algorithms in ACLS:

1. Cardiac Arrest Algorithm: Differentiates between shockable (VF/VT) and non-shockable rhythms (Asystole/PEA) and guides the use of defibrillation, medications, and CPR.
2. Bradycardia Algorithm: For symptomatic bradycardia, atropine is administered, followed by other interventions like transcutaneous pacing or administration of dopamine/epinephrine if unresponsive.
3. Tachycardia Algorithm: Differentiates between stable and unstable tachycardia, guiding use of synchronized cardioversion, vagal maneuvers, adenosine, or other antiarrhythmic drugs.

Key Concepts in ACLS:

• High-Quality CPR and Early Defibrillation: The cornerstones of ACLS in cardiac arrest management are timely, high-quality CPR and rapid defibrillation for shockable rhythms.
• Minimize Interruptions: Ensure compressions are interrupted for no more than 10 seconds for rhythm checks or defibrillation.
• Team Dynamics: ACLS involves coordination among multiple team members, with each person having a specific role. Clear communication and leadership are crucial for effective resuscitation.